Palmar-plantar erythrodysaesthesia syndrome due to 5-fluorouracil therapy--an underestimated toxic event?
Iurlo
A
A
Istituto di Scienze Mediche, Università degli Studi, Milano, Italy.
Fornier
M
M
Caldiera
S
S
Bertoni
F
F
Foa
P
P
D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D004890:Erythema / Q000139:chemically induced*; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D002955:Leucovorin / Q000008:administration & dosage; D008875:Middle Aged; D010292:Paresthesia / Q000139:chemically induced*; D013577:Syndrome
D000964:Antimetabolites, Antineoplastic; D002955:Leucovorin; D005472:Fluorouracil